GALERA THERAPEUTICS, INC.

Insiders Galera Therapeutics, Inc.

Equities

GRTX

US36338D1081

Market Closed - OTC Markets Other stock markets 15:51:34 2024-06-25 EDT			5-day change	1st Jan Change
0.1322 ^USD	+12.65%		+58.89%	-9.08%

06-07	Galera Therapeutics, Inc. Eliminates Robert A. Beardsley as Chief Operating Officer	CI
06-06	Galera Therapeutics, Inc.(OTCPK:GRTX) dropped from S&P TMI Index	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Galera Therapeutics, Inc. Eliminates Robert A. Beardsley as Chief Operating Officer	06-07	CI
Galera Therapeutics, Inc. Announces Elimination of Mark Bachleda, Pharm.D., Chief Commercial Officer	23-08-10	CI
Insider Buy: Galera Therapeutics	23-03-14	MT
Galera Therapeutics, Inc Appoints Eugene P. Kennedy as Chief Medical Officer	22-09-01	CI
Galera Therapeutics, Inc. Announces Executive Changes	21-10-12	CI
Insider Sell: Galera Therapeutics	21-09-03	MT
GaGalera Therapeutics, Inc. Announces Board Changes	20-04-02	CI
Galera Therapeutics, Inc. Appoints Christopher Degnan as Chief Financial Officer, Effective October 21, 2019	19-10-10	CI
Mike Powell Joins Galera Therapeutics Board of Directors	16-11-28	CI
Galera Therapeutics Appoints Thomas Dyrberg to the Board of Directors	15-10-14	CI
Galera Therapeutics, Inc. Announces Management Changes; Relocates its Headquarters from St. Louis to the Greater Philadelphia Area	12-12-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer